Medtech SAS: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Medtech SAS updates on initial public offering
Medtech SAS:Says Natixis and Oddo, joint lead managers and bookrunners of the company's initial public offering, did not exercise the over-allotment option.Says this means the final sum raised in the IPO is 20,000,007 euros, represented by 740,741 new shares.
Latest Developments for Medtech SAS
Latest Key Developments in Advanced
- SQI Diagnostics to begin Trading on OTCQX Marketplace in the United States
- Boston Scientific Corp receives CE Mark for Vercise Deep Brain Stimulation (DBS) system for treating patients with tremor
- China Resources Wandong Medical Equipment announces shareholding changes
- Nanosonics Ltd announces new European study showing trophon EPR high level disinfection for ultrasound probes significantly more effective than manual wipe disinfection
- Share this
- Digg this